AU8355998A — Medicinal compositions with cholesterol-lowering effect
Assigned to Yamanouchi Pharmaceutical Co Ltd · Expires 1999-02-16 · 27y expired
What this patent protects
Pharmaceutical compositions having a cholesterol-lowering effect which comprises as the active ingredient a compound having a PPAR (peroxisome proliferator-activated receptor) delta activating effect or a PPAR delta - and PPAR gamma -activating effect or a pharmaceutically accep…
USPTO Abstract
Pharmaceutical compositions having a cholesterol-lowering effect which comprises as the active ingredient a compound having a PPAR (peroxisome proliferator-activated receptor) delta activating effect or a PPAR delta - and PPAR gamma -activating effect or a pharmaceutically acceptable salt thereof; pharmaceutical compositions wherein the cholesterol-lowering effect is an LDL-cholesterol-lowering effect; and a method for identifying a compound having a cholesterol-lowering effect characterized by measuring the PPAR delta -activating effect or the PPAR delta - and PPAR gamma -activating effect thereof. Means for Solution: It is found out that a compound exerting an excellent cholesterol-lowering effect on higher animals such as humans and ape has an effect of activating PPAR delta or PPAR delta and PPAR gamma . Also, a method for identifying a compound having an excellent cholesterol-lowering effect was found, wherein the desired compound can be quickly and efficiently screened from among a number of compounds by measuring the PPAR delta -activating effect or the PPAR delta - and PPAR gamma -activating effect.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.